Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123097544 | 12309754 | 4 | F | 20110729 | 20160622 | 20160427 | 20160701 | EXP | CA-JNJFOC-20151126258 | JANSSEN | 13.62 | YR | C | M | Y | 66.00000 | KG | 20160701 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123097544 | 12309754 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | N | FGM59011;FIM76015;FIM79013 | 0 | 330 | MG | LYOPHILIZED POWDER | |||||
| 123097544 | 12309754 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | N | FGM59011;FIM76015;FIM79013 | 0 | 350 | MG | LYOPHILIZED POWDER | |||||
| 123097544 | 12309754 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | N | FGM59011;FIM76015;FIM79013 | 0 | 5 | MG/KG | LYOPHILIZED POWDER | |||||
| 123097544 | 12309754 | 4 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | N | FGM59011;FIM76015;FIM79013 | 0 | 350 | MG | LYOPHILIZED POWDER | |||||
| 123097544 | 12309754 | 5 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | N | FGM59011;FIM76015;FIM79013 | 0 | 400 | MG | LYOPHILIZED POWDER | |||||
| 123097544 | 12309754 | 6 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | N | FGM59011;FIM76015;FIM79013 | 103772 | 5 | MG/KG | LYOPHILIZED POWDER | |||||
| 123097544 | 12309754 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123097544 | 12309754 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123097544 | 12309754 | 9 | C | MESALAZINE | MESALAMINE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123097544 | 12309754 | 1 | Colitis ulcerative |
| 123097544 | 12309754 | 2 | Colitis ulcerative |
| 123097544 | 12309754 | 3 | Colitis ulcerative |
| 123097544 | 12309754 | 4 | Colitis ulcerative |
| 123097544 | 12309754 | 5 | Colitis ulcerative |
| 123097544 | 12309754 | 6 | Colitis ulcerative |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123097544 | 12309754 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123097544 | 12309754 | Abdominal pain | |
| 123097544 | 12309754 | Drug effect decreased | |
| 123097544 | 12309754 | Frequent bowel movements | |
| 123097544 | 12309754 | General physical health deterioration | |
| 123097544 | 12309754 | Haematochezia | |
| 123097544 | 12309754 | Off label use | |
| 123097544 | 12309754 | Product use issue | |
| 123097544 | 12309754 | Rectal haemorrhage | |
| 123097544 | 12309754 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123097544 | 12309754 | 1 | 20151124 | 0 | ||
| 123097544 | 12309754 | 2 | 20160419 | 0 | ||
| 123097544 | 12309754 | 3 | 20110729 | 0 | ||
| 123097544 | 12309754 | 4 | 20150512 | 0 | ||
| 123097544 | 12309754 | 5 | 20160301 | 0 | ||
| 123097544 | 12309754 | 6 | 201603 | 0 |